Starch safety in resuscitation

Show simple item record Hodgson, R.E. Richards, Guy A. Lundgren, A.C. Spruyt, M.G.L. Pretorius, Jan P. Mathiva, L.R. Dickerson, R. Gopalan, P.D. 2013-11-12T13:43:47Z 2013-11-12T13:43:47Z 2013-09
dc.description.abstract The Western Cape Department of Health (WC DoH) has taken a decision to withdraw all intravenous fluids (IVFs) containing hydroxyethyl starch (HES) from hospitals in the Western Cape, with similar action contemplated in the Free State and Gauteng. This was in response to recommendations from: The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (EMA PRAC) that HES IVFs be withdrawn from clinical use. The United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA) which has issued a recall of all HES IVFs in the UK. The United States Food and Drug Administration which advises that HES IVFs be used with caution in ICU, cardiac surgery and patients with known kidney disease or coagulopathy. Further advice was that HES should be stopped if coagulopathy or renal dysfunction develops, as well as that renal function should be monitored for 90 days after HES administration. en_US
dc.description.librarian am2013 en_US
dc.description.librarian ay2013 en
dc.description.uri en_US
dc.identifier.citation Hodgson, RE, Richards, GA, Lundgren, AC, Spruyt, MGL, Pretorius, JP, Mathiva, LR, Dickerson, R & Gopalan, PD 2013, 'Starch safety in resuscitation', South African Medical Journal, vol. 103, no. 9, pp. 591-592. en_US
dc.identifier.issn 2078-5135 (online)
dc.identifier.issn 0256-9574 (print)
dc.language.iso en en_US
dc.publisher Health and Medical Publishing Group en_US
dc.rights Health and Medical Publishing Group en_US
dc.subject Starch safety en_US
dc.subject Resuscitation en_US
dc.subject.lcsh Critical care medicine -- Complications en
dc.title Starch safety in resuscitation en_US
dc.type Article en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record